RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:RainDance Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014372
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR system, an unified platform for NGS amplicon enrichment and digital PCR. RDT’s consumables include source chips, sense chips and oil surfactants. It also offers next-generation sequencing enrichment solutions, among others. The company serves academic and translational research institutions, pharmaceutical and biotechnology companies, agricultural and industrial clients, cancer centers, bio-banks, commercial laboratories, and government institutions. It distributes its products through a network of distributors across Asia Pacific and EMEA regions. RDT is headquartered in Billerica, Massachusetts, the US.

RainDance Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RainDance Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RainDance Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 11
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
RainDance Technologies Secures US$37.5 Million In Series D Financing 14
Partnerships 15
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 17
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 18
Asset Transactions 19
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 19
Acquisition 21
Bio-Rad Labs to Acquire RainDance Technologies 21
RainDance Technologies Inc – Key Competitors 22
RainDance Technologies Inc – Key Employees 23
RainDance Technologies Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Jun 29, 2016: RainDance Technologies Appoints Kathy Ordonez as Chief Executive Officer 25
Legal and Regulatory 26
Jan 20, 2017: 10x Genomics Invalidates RainDance Technologies Patent 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RainDance Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RainDance Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
RainDance Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
RainDance Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RainDance Technologies Raises US$16.5 Million In Extended Series E Financing 11
RainDance Technologies Raises US$35 Million In Venture Financing 12
RainDance Technologies Raises US$20 Million In Series E Financing 13
RainDance Technologies Secures US$37.5 Million In Series D Financing 14
Pacific Biosciences Enters into Co-Development and Co-Marketing Agreement with RainDance Technologies 15
RainDance Technologies Enters Into Co-Development Agreement With Integrated DNA Technologies For Digital PCR 16
RainDance Technologies Enters Into Co-Development Agreement With MLL Munchner Leukamie Labor 17
RainDance Technologies Enters Into Co-Development Agreement With Sony DADC Austria 18
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 19
Bio-Rad Labs to Acquire RainDance Technologies 21
RainDance Technologies Inc, Key Competitors 22
RainDance Technologies Inc, Key Employees 23

★海外企業調査レポート[RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Electric Cooperative Corp:企業の戦略的SWOT分析
    First Electric Cooperative Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nippon Life Insurance Company:企業の戦略・SWOT・財務情報
    Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Avalign Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners LP is a medical device company that offers cutting instruments. The company offers cutting instruments, cases and trays, german instruments and instruments and implant products. It manufactures instruments and imp …
  • Rackspace Hosting, Inc.:企業の戦略・SWOT・財務情報
    Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rackspace Hosting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hyundai Heavy Industries Co., Ltd.:戦略・SWOT・企業財務分析
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • McCarthy & Stone Plc:企業の戦略・SWOT・財務分析
    McCarthy & Stone Plc - Strategy, SWOT and Corporate Finance Report Summary McCarthy & Stone Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Grupo Grana y Montero SAA (GRAMONC1):企業の財務・戦略的SWOT分析
    Grupo Grana y Montero SAA (GRAMONC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Perstorp Holding AB:企業の戦略的SWOT分析
    Perstorp Holding AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Audi AG (NSU):企業の財務・戦略的SWOT分析
    Audi AG (NSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • MKS Instruments Inc (MKSI):企業の財務・戦略的SWOT分析
    MKS Instruments Inc (MKSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Islet Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • BAE Systems Australia:企業の戦略・SWOT・財務情報
    BAE Systems Australia - Strategy, SWOT and Corporate Finance Report Summary BAE Systems Australia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Industrial and Commercial Bank of China Ltd:戦略・SWOT・企業財務分析
    Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Industrial and Commercial Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Entegris Inc (ENTG):企業の財務・戦略的SWOT分析
    Summary Entegris Inc (Entegris) is a manufacturer and supplier of micro contamination control products, specialty chemicals, and advanced materials handling solutions. The company offers products for wafer shipping and processing; gas filtration and purification; mask and reticle handling; hard disk …
  • Nielsen Holdings PLC:企業のM&A・事業提携・投資動向
    Nielsen Holdings PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nielsen Holdings PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Teijin Ltd (3401)-医療機器分野:企業M&A・提携分析
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆